Propolis blocks PAK-1 and and can contributes to alleviation of COVID-19 symptoms
Propolis can block PAK-1, a pathogenic kinase. When abnormally activated, it plays a key role in the development of cancer, malaria and viral infections, inflammation and immune-suppression. Lung fibrosis, a symptom in COVID-19 patients, is a consequence of PAK-1 activation.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Propolis leads to reduction of pro-inflammatory cytokines
Propolis is an effective adjuvant therapy for multiple COVID-19 patient comorbidities
Propolis Interacts with the Main Protease of SARS-CoV-2
Propolis can Potentially Prevent SARS-CoV-2 from Binding to ACE2
The potential for kaempferol in propolis to treat COVID-19
Propolis blocks PAK-1 and and can contributes to alleviation of COVID-19 symptoms
Immunostimulatory Properties of Propolis
Propolis as a Potential COVID-19 Vaccine Adjuvant
Propolis Administration for COVID-19 Treatment and Prevention